Insider selling
Traded Jun 24 · filed 1 day laterNot reported under a pre-arranged trading plan
Becton Dickinson's & Pres Med.Essntl&BioPharm sold $160K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded May 26, 2026 · Filed May 27, 2026
Becton Dickinson's Chief Revenue Officer sold $11K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$11,051
Shares × reported transaction price
19 days after results of May 7, 2026, 72 days before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $147.75 on May 26, 2026, within 4% of its 52-week low, after a 5% drop over the previous 30 trading days
52-week range $142.35 (May 18, 2026) to $210.02 (Feb 6, 2026), 8% of the way up, from 251 adjusted closes. 30 trading days earlier: $155.43 on Apr 13, 2026. Describes the past only, not a forecast
RSI 48, 18% under its 200-day average, 3% under its 50-day average, 30% below the 52-week high, 20-day volatility 37% a year, against the S&P 500: −8 points over 1 month, −28 points over 3 months, −37 points over 6 months
From the adjusted closes up to May 26, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.8% | +0.3% | +0.4% |
| 30 days | +4.6% | −1.8% | +6.4% |
| 90 days | +28.2% | +1.5% | +26.6% |
Past results only. Not a forecast.
Insider selling
Traded Jun 24 · filed 1 day laterNot reported under a pre-arranged trading plan
Becton Dickinson's & Pres Med.Essntl&BioPharm sold $160K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Congress
Traded May 21 · disclosed 28 days laterSits on House Energy and Commerce
Michael David Garrison (EVP & Pres Med.Essntl&BioPharm) sold ~$167K of Becton Dickinson
Automatic saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.